We are live on ! Find out more
RC

Rangeley Capital Portfolio holdings

AUM $103M
1-Year Est. Return 77.32%
This Fund
S&P 500
This Quarter Est. Return
-3.19%
1 Year Est. Return
+77.32%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$103M
AUM Growth
-$17.5M
Cap. Flow
-$2.25M
Cap. Flow %
-2.19%
Top 10 Hldgs %
35.28%
Holding
169
New
46
Increased
35
Reduced
35
Closed
32

Top Buys

Rank Stock Value
1
DRVN icon
Driven Brands
DRVN
+$8.81M
2
RVMD icon
Revolution Medicines
RVMD
+$6.74M
3
ICLR icon
Icon
ICLR
+$2.42M
4
TRIP icon
TripAdvisor
TRIP
+$2.21M
5
ELME
Elme Communities
ELME
+$2.17M

Sector Composition

Rank Sector Weight
1 Healthcare 29.22%
2 Consumer Discretionary 17.78%
3 Real Estate 12.14%
4 Financials 8.26%
5 Technology 4.93%

No holdings matched the selected filter criteria.

Similar funds

Rangeley Capital's Q1 2026 Portfolio in Review

As of Q1 2026, Rangeley Capital held 169 positions worth $103M, down 15% from $120M the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Rangeley Capital's Q1 2026 filing shows 46 new, 35 increased, 35 reduced and 32 closed positions. Its largest new stake was Driven Brands: 625,500 shares worth $7.89M. The largest sale was Golden Entertainment, an estimated $5.71M.

By sector, the portfolio is most concentrated in Healthcare at 29% of assets, down from 33% a quarter earlier, followed by Consumer Discretionary and Real Estate.

  • Rangeley Capital's largest Q1 2026 buy was Driven Brands: 625,500 shares worth $7.89M.
  • Rangeley Capital added most to Janux Therapeutics in Q1 2026, an estimated $1.33M increase.
  • Rangeley Capital's biggest Q1 2026 reduction was Calumet Specialty Products, cutting an estimated $5.34M.
  • Rangeley Capital fully exited Golden Entertainment in Q1 2026, selling an estimated $5.71M.
  • Rangeley Capital's ten largest holdings make up 35% of its $103M portfolio in Q1 2026.
  • Rangeley Capital opened 46 new positions and closed 32 in Q1 2026.
  • Rangeley Capital's portfolio value fell 15% quarter-over-quarter to $103M.

Based on Rangeley Capital's 13F filing for Q1 2026, filed 15 May 2026.